Breakthrough Vascular Organoids Model Sheds Light on Capillary Malformation Mechanisms

Vascular Organoids: A New Window into Capillary Malformation Research

Capillary malformations (CMs), often recognized as port-wine birthmarks, are congenital vascular anomalies affecting the skin, mucosa, eyes, and brain. Despite their prevalence, the lack of preclinical models has severely limited research into the mechanisms and treatments for these conditions—until now.

A groundbreaking study has successfully created vascular organoids (VOs) using induced pluripotent stem cells (iPSCs) derived from CM patients, providing a 3D in vitro platform to explore disease mechanisms and test potential therapies.

How Scientists Created the Vascular Organoids

The research team generated iPSCs from skin biopsies of patients with nodular capillary malformations. These cells were then differentiated into endothelial cells (iECs) and smooth muscle cells (iSMCs)—the building blocks of blood vessels.

Through a process of self-assembly, the iECs and iSMCs organized into vascular networks, forming miniaturized vascular systems that closely mimic human blood vessels.

Key steps included:

Mesoderm induction to push iPSCs toward vascular lineages
3D spheroid culture to encourage self-organization
Growth factor stimulation with VEGF, FGF, and BMP4 to promote vessel development
Light-sheet microscopy imaging to visualize the complex vascular structures

Key Findings: Disease-Relevant Phenotypes

Compared to organoids from healthy control iPSCs, CM-derived vascular organoids showed:

Higher densities of endothelial and smooth muscle cells
Greater vascular branching lengths
Preservation of disease-relevant vascular abnormalities

This means the organoids effectively recapitulate CM pathology in vitro, allowing researchers to study disease progression and test interventions in a controlled lab setting.

Why This Matters for Medical Research

First-of-its-Kind CM Model
This is the first vascular organoid model directly derived from patient iPSCs, providing a clinically relevant tool for understanding CM biology.
Drug Screening Potential
Researchers can now test new drugs on these organoids before moving to animal or clinical studies, accelerating the search for effective treatments.
Insights into Vascular Biology
The model offers a platform to study vascular development, remodeling, and inflammation—processes critical not only in CMs but also in stroke, diabetes, and tumor angiogenesis.

Challenges and Future Directions

While revolutionary, the study notes several limitations:

The model lacks immune cells and blood flow dynamics, both important for disease progression.
Functional assays such as barrier integrity and inflammatory responses remain to be tested.
Integration with gene editing tools like CRISPR could help explore the role of specific mutations in CM pathology.

Conclusion: A Powerful Tool for Vascular Disease Research

By developing vascular organoids from patient-derived iPSCs, scientists have created a new model system that mimics CM-like vascular abnormalities in the lab.

This technology opens doors for:

Mechanistic studies to unravel disease pathways
Personalized medicine approaches for CM patients
High-throughput drug screening for vascular disorders

Ultimately, this breakthrough could pave the way for better treatments and improved quality of life for patients with capillary malformations.

Reference

Nguyen, V., Harper, A., Azuero, M., Castellanos, I., He, S., Hochman, M. L., Wenceslau, C. F., Chen, D., Jegga, A. G., Wang, Y., Fan, D., Nelson, J. S., & Tan, W. (2025). Vascular Organoids Derived from Capillary malformation-induced Pluripotent Stem Cells Exhibit Disease-Relevant Phenotypes. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-025-10984-8